Methods of sympathetic activity evaluation in patients with systemic refractory hypertension
Abstract
About the Authors
V. A. GriginRussian Federation
N. M. Danilov
Russian Federation
O. V. Sagaydak
Russian Federation
G. V. Shelkova
Russian Federation
I. Ye. Chazova
Russian Federation
References
1. Papademetriou V, Doumas M, Tsioufis K. Renal Sympathetic Denervation for the Treatment of Difficult - to - Control or Resistant Hypertension. Int J Hypertens 2011; 2011: 196518; doi: 10.4061/2011/196518
2. Chen S.L, Zhang Y.J, Xie D.J et al. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo. Eurointervention 2013; 9 (2): 269-76.
3. Chen S.L, Zhang F.F, Xu J et al. Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension: The Single-Center, Prospective, First - in - Man PADN-1 Study (First - in - Man Pulmonary Artery Denervation for Treatment of Pulmonary Artery Hypertension) J Am Coll Cardiol 2013; 62 (12): 1092-100.
4. Bhatt D.L, Kandzari D.E, O'Neill W.W et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-401.
5. Patel H.C, Rosen S.D, Alistair L et al. Targeting the autonomic nervous system: Measuring autonomic function and novel devices for heart failure management. Int J Cardiol 2013; 170: 107-17.
6. Floras J. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 2009; 54: 375-85.
7. Buchheit M, Laursen P.B, Ahmaidi S. Parasympathetic reactivation after repeated sprint exercise. Am J Physiol Heart Circ Physiol 2007; 293: H133-H141.
8. Guidelines. Heart rate variability.Standards of measurement, physiological in terpretation, and clinical use. Eur Heart J 1996; 17: 354-81.
9. Appel M.L, Saul J.P, Berger R.D, Cohen R.J. Closed loop identification of cardio - vascular circulatory mechanisms. Computers in Cardiology 1989. Los Alamitos: IEEE Press, 1990; 3-7.
10. Corr P.B, Yamada K.A, Witkowski F.X. Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis. In: Fozzard H.A, Haber E, Jennings R.B et al. Heart and Cardiovascular System, New York: Raven Press, 1986; p. 1343-403.
11. Schwartz P.J, Priori S.G. Sympathetic nervous system and cardiac arrhythmias. In: Zipes D.P, Jalife J eds. Cardiac Electrophysiology. From Cell to Bedside. Philadelphia: WB Saunders, 1990; p. 330-43.
12. Levy M.N, Schwartz P.J.Vagal control of the heart: Experimental basis and clinical implications. Armonk: Future, 1994.
13. Рябыкина Г.В., Соболев А.В. Вариабельность ритма сердца. М.: СтарКо, 1998.
14. Habib G.B. Reappraisal of heart rate as a risk factor in the general population. Eur Heart J 1999; (Suppl. H): H2-H10.
15. Parati G, Saul G.P, Di Rienzo M, Mancia G. Spectral analyses of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension 1995; 25: 1276-86.
16. Tsuji H, Venditti F.J, Manders E.S et al. Reduced heart rate variability and mortality risk in an elderly cohort: The Framingham Study. Circulation 1994; 90: 878-83.
17. Аронов Д.М., Лупанов В.П. Функциональные пробы в кардиологии. М.: Медицина; 2003. с.296.
18. Borresen J, Lambert M.I. Autonomic control of heart rate during and after exercise: Measurements and implications for monitoring training status. Sports Med 2008; 38: 633-46.
19. Esler M, Jackman G, Bobik A et al. Norepinephrine kinetics in essential hypertension.Defective neuronal uptake of norepinephrine in some patients. Hypertension 1981; 3: 149-56.
20. Esler M, Hasking G, Willett I et al. Editorial review: noradrenaline release and sympathetic nervous system activity. J Hypertens 1985; 3: 117-29.
21. Esler M, Eikelis N, Schlaich M et al. Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder. Ann NY Acad Sci 2008; 1148: 338-48.
22. Meredith I.T, Eisenhofer G, Lambert G.W et al. Plasma noradrenaline responses to head - up tilt are misleading in autonomic failure. Hypertension 1992; 19: 628-33.
23. Esler M, Jackman G, Bobik A et al. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 1979; 25: 1461-70.
24. Mancia and Grassi. Circ Res 2014; 114: 1804-1814.
25. Esler M, Lambert E, Schlaich M. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol 2010; 109: 1996-8.
26. Krum H, Schlaich M.P, Whitbourn R et al. Catheter - based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof - of - principle cohort study. Lancet 2009; 373: 1275-81.
27. Smith P et al. Am J Hypertens 2004; 17: 217-22.
28. Leimbach W, Wallin B, Victor R et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73: 913-9.
29. Barretto A, Santos A, Munhoz R et al. Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol 2009; 135: 302-7.
30. Schlaich M, Sobotka P, Krum H et al. Renal sympathetic - nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361: 932-3.
31. Bengel F. Imaging targets of the sympathetic nervous system of the heart: translational considerations. J Nucl Med 2011; 52: 1167-70.
32. Mahfoud F et al. Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension. Circulation 2011; 123: 1940-6.
Review
For citations:
Grigin V.A., Danilov N.M., Sagaydak O.V., Shelkova G.V., Chazova I.Ye. Methods of sympathetic activity evaluation in patients with systemic refractory hypertension. Systemic Hypertension. 2014;11(4):21-26.
Email this article 